securities fraud

Schall Law Firm seeks $FSK investors for class action lawsuit alleging false statements on portfolio restructuring, valuations, and dividend strength between May 2024 and February 2026.

Grabar Law Office investigates four companies for alleged securities fraud involving false statements about business performance, causing stock price inflation and investor losses.

Kirby McInerney LLP files class action against POET Technologies for alleged securities fraud involving PFIC misrepresentation and confidentiality breaches, triggering steep stock declines.

The Schall Law Firm investigates LakeShore Biopharma for alleged securities violations, including false statements and material information failures, recruiting affected shareholders.

Schall Law Firm investigates Cross Country Healthcare ($CCRN) for alleged securities violations involving false statements or material disclosure failures to investors.

Schall Law Firm files class action against $SES for alleged false statements about deal results and Molecular Universe platform misrepresentations.

$GPK faces securities fraud class action alleging false statements about inventory, costs, and demand between February 2025 and 2026.

Law firm sues $GO over alleged failure to disclose aggressive store expansion that inflated growth metrics, requiring future closures and write-downs.

Law firm files securities fraud class action against $ALIT, alleging management made misleading statements about growth and sales capabilities between Nov 2024-Feb 2026.

Power Solutions International faces securities fraud lawsuit for allegedly overstating data center demand and understating costs between May 2025 and March 2026.

Law Offices of Frank R. Cruz filed class action against New Era Energy & Digital ($NUAI) alleging undisclosed project delays and fraudulent remediation scheme.

SES AI faces class action securities fraud suit alleging misrepresented business prospects, inflated revenues through circular transactions, and concealed logistics constraints affecting Q4 2025.

Graphic Packaging faces class action lawsuit alleging executives misrepresented inventory issues, demand weakness, and cost pressures from Feb 2025-Feb 2026.

Four public companies face securities fraud class actions with mid-to-late June 2026 lead plaintiff deadlines. Investors alleged false statements about business operations and financial prospects.

Robbins LLP sues $GLOB for misleading investors about Latin American business. Stock plunged 15% after company disclosed declining demand, wage freezes, and $47.6M restructuring charge.

Robbins LLP filed class action against $LKQ for allegedly misleading investors about Uni-Select acquisition benefits, citing undisclosed FinishMaster customer losses.

Class action lawsuit filed against $MNDY alleging materially false 2027 revenue guidance. Stock plummeted 33% after company rescinded $1.8B target and warned of growth slowdown.

ImmunityBio faces securities fraud lawsuit after FDA warning letter alleges false Anktiva promotional claims. Stock dropped 21% to $7.42.

Graphic Packaging faces class action lawsuit for allegedly concealing inventory, demand, and cost problems, following 15.57% stock plunge from negative Q1 guidance.

Class action lawsuit filed against $PINS alleging false statements on ad revenues, tariff impacts, and undisclosed restructuring plans affecting investors from Feb 2025-2026.